|
|
Relationship between antibiotic susceptibility and genotype of Mycobacterium abscessus clinical isolates |
MAO Yanhua CHU Haiqing |
Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Shanghai 200433, China |
|
|
Abstract Objective To observe the relationship between antibiotic susceptibility and genotype of clinical isolates of Mycobacterium abscessus. Methods From January 2016 to September 2018, 87 strains of Mycobacterium abscess isolated from Shanghai Pulmonary Hospital were selected for the study. Among them, 72 strains were sputum and 15 strains were bronchoalveolar lavage fluid. All strains were identified as Nontuberculous mycobacteria by MGIT960 medium growth and p-nitrobenzoic acid test, while further identified as Mycobacterium abscessus by sequencing rPOB gene. All strains were subjected to quantitative polymerase chain reaction amplification, while single nucleotide polymorphism analysis was performed using NCBI Nucleotide blast program. Antibiotic sensitivity was determined by microdilution method, while the relationship between antibiotic sensitivity and genotype was analyzed. Results Eighty-seven isolates included 81 subsp.abscessus, 6 subsp.massiliense. A total of 72 ERM (41) T28 sequences and 9 ERM (41) C28 sequences in 81 subsp.abscessus, and ERM (41) sequences to 10 species were sensitivity to antibiotics. 81 subsp.abscessu subtypes included 41 Claroycin (CLA) -sensitive strains and 10 CLA-mediated strains, 8 ERM (41) C28 and 43 ERM (41) T28 isolates without rrl 2058/2059 mutation. 30 resistant isolates were consisted of 29 ERM (41) T28 isolates (5 of them had rrl 2058/2059 mutations) and 1 ERM (41) C28 isolate (1 occurred the rrl 2058/2059 mutation). There were 2 subsp.massiliense resistant isolates, and 1 had a rrl 2058/2059 mutation. Conclusion The rrl and ERM (41) genotypes have a certain predictive effect on CLA resistance of clinical isolates of abscess abacillus. The treatment of Mycobacterium abscessus with Amikacin may have better effect and it is worthy of further study.
|
|
|
|
|
[1] Bastian S,Veziris N,Roux AL,et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by ERM(41)and rrl sequencing [J]. Antimicrob Agents Chemother,2011,55(2):775-781.
[2] Baliga S,Murphy C,Sharon L,et al. Rapid method for detecting and differentiating Mycobacterium tuberculosis complex and non-tuberculous mycobacteria in sputum by fluorescence in situ hybridization with DNA probes [J]. Int J Infect Dis,2018,75:1-7.
[3] Kim HJ,Cho Y,Lee S,et al. Mycobacterium massiliense outbreak after intramuscular injection,South Korea [J]. Epidemiol Infect,2012,140(10):1880-1887.
[4] 余斐,陈晓,嵇仲康,等.杭州地区2009~2014年非结核分枝杆菌流行状况分析[J].中国微生态学杂志,2016,28(7):808-810,815.
[5] 陈华,陈品儒,苏铎华,等.非结核分枝杆菌分布特点与耐药性分析[J].中华医院感染学杂志,2012,22(23):5419-5421.
[6] 潘建华,石国民,彭雪峰,等.长沙地区2012~2017年非结核分枝杆菌流行状况分析[J].国际检验医学杂志,2018, 39(20):2496-2498.
[7] 聂文娟,段鸿飞,黄海荣,等.脓肿分枝杆菌菌种鉴定及药物敏感试验研究[J].中华结核和呼吸杂志,2014,37(7):517-521.
[8] Chu H,Zhao L,Xiao H,et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis:a meta-analysis [J]. Arch Med Sci,2014,10(4):661-668.
[9] Golus J,Sawicki R,Widelski J,et al. The agar microdilution method——a new method for antimicrobial susceptibility testing for essential oils and plant extracts [J]. J Appl Microbiol,2016,121(5):1291-1299.
[10] 吴正吉,杨致邦,于拽拽,等.脓肿分支枝杆菌embB基因耐乙胺丁醇的分析[J].中国微生态学杂志,2012,24(4):307-310.
[11] Bernut A,Le Moigne V,Lesne T,et al. In vivo assessment of drug efficacy against Mycobacterium abscessus using the embryonic zebrafish test system [J]. Antimicrob Agents Chemother,2014,58(7):4054-4063.
[12] Nasr Esfahani B,Zarkesh Esfahani FS,Bahador N,et al. Analysis of DNA gyrA Gene Mutation in Clinical and Environmental Ciprofloxacin-Resistant Isolates of Non-Tuberculous Mycobacteria Using Molecular Methods [J]. Jundishapur J Microbiol,2016,9(3):e30018.
[13] 沙巍,翁心华,肖和平,等.脓肿分枝杆菌耐利福平情况及rpoB基因序列的研究[J].中华结核和呼吸杂志,2003, 26(9):544-547.
[14] Fan LC,Xu JF. Advantages and drawbacks of long-tERM macrolide use in the treatment of non-cystic fibrosis bronchiectasis [J]. J Thorac Dis,2014,6(7):867-871.
[15] Garcia de,Carvalho NF,Sato DN,et al. Resazurin microtiter assay for clarithromycin susceptibility testing of clinical isolates of Mycobacterium abscessus group [J]. J Clin Lab Anal,2016,30(5):751-755.
[16] Nuru A,Zewude A,Mohammed T,et al. Nontuberculosis mycobacteria are the major causes of tuberculosis like lesions in cattle slaughtered at Bahir Dar Abattoir,northwestern Ethiopia [J]. BMC Vet Res,2017,13(1):237.
[17] Lee SH,Yoo HK,Kim SH,et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea [J]. Ann Lab Med,2014,34(1):31-37.
[18] Mougari F,Amarsy R,Veziris N,et al. Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and ERM41 sequevar [J]. J Antimicrob Chemother,2016,71(18):2208-2212.
[19] Maurer FP,Ruegger V,Ritter C,et al. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible ERM(41) [J]. J Antimicrob Chemother,2012, 67(11):2606-2611.
[20] Nessar R,Reyrat JM,Murray A,et al. Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus [J]. J Antimicrob Chemother,2011,66(8):1719-1724. |
|
|
|